Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Boyraz B, Watkins JC, Young RH, Oliva E. Uterine Tumors Resembling Ovarian Sex Cord Tumors: A Clinicopathologic Study of 75 Cases Emphasizing Features Predicting Adverse Outcome and Differential Diagnosis. Am J Surg Pathol. 2023;47(2):234-247.

Stagg J, Golden E, Wennerberg E, Demaria S. The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy. Sci Immunol. 2023;8(85):eabq3015.

Liu W, Newhall KP, Khani F, Barlow LM, Nguyen D, Gu L, et al. The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer. Cancer Res. 2023;83(4):506-520.

Li F, Wang Y, Hwang I, Jang J-, Xu L, Deng Z, et al. Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenance. bioRxiv. 2023.

Saldarriaga MM, Alhomoud M, Roboz G, Allan JN, Ruan J, Ouseph MM, et al. Angioimmunoblastic T-cell lymphoma presenting with severe plasmacytosis mimicking plasma cell leukemia. Am J Hematol. 2023;98(7):1119-1126.

Ruiz-Uribe NE, Bracko O, Swallow M, Omurzakov A, Dash S, Uchida H, et al. Vascular oxidative stress causes neutrophil arrest in brain capillaries, leading to decreased cerebral blood flow and contributing to memory impairment in a mouse model of Alzheimerâ€™s disease. bioRxiv. 2023.

Velu PD, Sipley J, Marino J, Ghanshani S, Lukose G, Cong L, et al. Evaluation of a Zoonotic Orthopoxvirus PCR Assay for the Detection of Mpox Virus Infection. J Mol Diagn. 2023;25(10):740-747.

Nuzzo PV, Ravera F, Saieva C, Zanardi E, Fotia G, Malgeri A, et al. Clinical outcomes of volume of disease on patients receiving enzalutamide versus abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer. Ther Adv Med Oncol. 2023;15:17588359231156147.

Nguyen-Dien GT, Kozul K-, Cui Y, Townsend B, Kulkarni PG, Ooi SS, et al. FBXL4 suppresses mitophagy by restricting the accumulation of NIX and BNIP3 mitophagy receptors. EMBO J. 2023;42(13):e112767.

Chaudagar K, Hieromnimon HM, Kelley A, Labadie B, Shafran J, Rameshbabu S, et al. Suppression of tumor cell lactate-generating signaling pathways eradicates murine PTEN/p53-deficient aggressive-variant prostate cancer via macrophage phagocytosis. bioRxiv. 2023.